NGS based RNA sequencing market is expected to reach US$ 7,984.90 Mn By 2027

The global NGS based RNA sequencing market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.

The research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the NGS-Based RNA-Sequencing market during the forecast period, i.e., 2020–2027. Most importantly, the report further identifies the qualitative impact of various market factors on market segments and geographies. The research segments the market on the basis of product type, application, technology, and region. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries.

Sample Report @

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. The region is expected to be the fastest growing due to the key factors such as increasing investments by the respective government, growing number of the next generation sequencing workshops and conferences and development done by the companies. In addition, the introduction of the next generation sequencing based RNA sequencing based products by the companies are growing.

Market Insights:

The growth in the adoption of the next generation sequencing is rising, recently in few years, next generation sequencing price have reduced greatly. For instance, first whole human genome sequencing cost over US$ 3billion in 2001 and it took approximately 15 years for its completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. The cost of sequencing was approximately US$ 3 billion, which dropped down to US$ 10 million in 2006 and as the development in the technologies as increased the prices of sequencing has decreased to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing. Moreover, the increase in the service provider companies have entered the market and they are offering next generation sequencing in cheaper cost.

Competitive scenario:

The study assesses factors such as segmentation, description, and applications of NGS-Based RNA-Sequencing industries. It derives accurate insights to give a holistic view of the dynamic features of the business, including shares, profit generation, thereby directing focus on the critical aspects of the business.

Scope of the Report

The research on the NGS-Based RNA-Sequencing market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The research also segments the NGS-Based RNA-Sequencing market on the basis of end user, product type, application, and demography for the forecast period 2021–2027. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

NGS-Based RNA-Sequencing Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

Major highlights of the report:

  • All-inclusive evaluation of the parent market
  • Evolution of significant market aspects
  • Industry-wide investigation of market segments
  • Assessment of market value and volume in past, present, and forecast years
  • Evaluation of market share
  • Study of niche industrial sectors
  • Tactical approaches of market leaders
  • Lucrative strategies to help companies strengthen their position in the market

The Emerging Players in the NGS-Based RNA-Sequencing Market includes

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Pacific Biosciences of California, Inc.
  • F, Hoffman-La Roche Ltd
  • Agilent Technologies
  • BGI
  • Oxford Nanopre Technologies
  • Eurofins Scientific
  • Qiagen
  • Perkinelmer Inc.

The research provides answers to the following key questions:

  • What is the estimated growth rate of the market for the forecast period 2020–2027? What will be the market size during the estimated period?
  • What are the key driving forces responsible for shaping the fate of the NGS-Based RNA-Sequencing market during the forecast period?
  • Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the NGS-Based RNA-Sequencing market?
  • What are the prominent market trends influencing the development of the NGS-Based RNA-Sequencing market across different regions?
  • What are the major threats and challenges likely to act as a barrier in the growth of the NGS-Based RNA-Sequencing market?
  • What are the major opportunities the market leaders can rely on to gain success and profitability?

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

Contact Us:

The Insight Partners,

Phone: +1-646-491-9876


Related Posts

Subscribe Our Newsletter